Pros

Exness launches Exness Team Pro with line-up of top global influencers

Retrieved on: 
Wednesday, November 8, 2023
Pros, Human, Tipp-Ex

LIMASSOL, Cyprus, Nov. 8, 2023 /PRNewswire/ -- Earlier this year, multi-asset broker Exness announced the launch of its new influencer program, Exness Team Pro, through which it has leveraged the influence of international trading professionals, each possessing a large following and established voice within their respective communities.

Key Points: 
  • LIMASSOL, Cyprus, Nov. 8, 2023 /PRNewswire/ -- Earlier this year, multi-asset broker Exness announced the launch of its new influencer program, Exness Team Pro, through which it has leveraged the influence of international trading professionals, each possessing a large following and established voice within their respective communities.
  • The members of Exness Team Pro are: Nicolas Palacios, Momen Medhat, Mohsin Sher, Dennis Okari and Kojo Forex.
  • This ensemble, who act as Exness' brand ambassadors, play a key role in crafting valuable storytelling around the broker's offerings, value proposition, differentiation, and credibility.
  • Through their content, the Pros share their unique perspective on trading - their success stories, testimonials, and experiences - becoming an authentic voice for Exness and extending its reach to relevant audiences.

Exness launches Exness Team Pro with line-up of top global influencers

Retrieved on: 
Wednesday, November 8, 2023
Pros, Human, Tipp-Ex

LIMASSOL, Cyprus, Nov. 8, 2023 /PRNewswire/ -- Earlier this year, multi-asset broker Exness announced the launch of its new influencer program, Exness Team Pro, through which it has leveraged the influence of international trading professionals, each possessing a large following and established voice within their respective communities.

Key Points: 
  • LIMASSOL, Cyprus, Nov. 8, 2023 /PRNewswire/ -- Earlier this year, multi-asset broker Exness announced the launch of its new influencer program, Exness Team Pro, through which it has leveraged the influence of international trading professionals, each possessing a large following and established voice within their respective communities.
  • The members of Exness Team Pro are: Nicolas Palacios, Momen Medhat, Mohsin Sher, Dennis Okari and Kojo Forex.
  • This ensemble, who act as Exness' brand ambassadors, play a key role in crafting valuable storytelling around the broker's offerings, value proposition, differentiation, and credibility.
  • Through their content, the Pros share their unique perspective on trading - their success stories, testimonials, and experiences - becoming an authentic voice for Exness and extending its reach to relevant audiences.

Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

Retrieved on: 
Tuesday, November 7, 2023
Generalized arterial calcification of infancy, Patient, Research, Research and development, Genomics, Clinical trial, PD, Calciphylaxis, Therapy, Biomarker, ESKD, G&A, American Society of Nephrology, Conference, Pros, Kidney disease, R, American Society for Bone and Mineral Research, Society, PXE, Columbia University School of General Studies, ENPP1, ASN, PK, Clinical Global Impression, Annual general meeting, GIC, Safety, ABCC6, Investment, Doctor of Philosophy, Administration, Nursing, Pharmaceutical industry

BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today reported financial results for the third quarter ended September 30, 2023 and provided business highlights.

Key Points: 
  • Patient recruitment is underway, and the Company remains on track to report topline data in mid-2025.
  • Exploratory efficacy data reported suggested clinical benefit for ENPP1 Deficiency, including improvement in key biomarkers, patient-reported outcomes (PROs), and functional outcomes.
  • R&D Expenses were $13.3 million for the quarter ended September 30, 2023, compared to $12.2 million for the prior-year period.
  • Net loss was $16.6 million, or $0.29 loss per share, for the quarter ended September 30, 2023, compared to $16.4 million, or $0.38 loss per share, for the prior-year period.

Apple Unveils Next-Gen MacBook Pros and iMacs With M3-Series Chips; Preorder and More Info at B&H

Retrieved on: 
Tuesday, October 31, 2023
Technology, Other Retail, Other Technology, Photography, Software, Audio, Video, Hardware, Retail, Consumer Electronics, Online Retail, Pros, XDR, Macs, MacBook Pro, IMac, Life, Apple A11, SDR, MacBook, Intel, CPU, Retina display, GPU, Meizu M3 Max, Graphics processing unit, Memory, A17, MacBook Pro (Apple silicon), Mac, Video game, Apple, M1, M3

Alongside the M3 is the introduction of a next-generation GPU, which Apple claims is going to mark the biggest jump in graphical fidelity for the Mac platform.

Key Points: 
  • Alongside the M3 is the introduction of a next-generation GPU, which Apple claims is going to mark the biggest jump in graphical fidelity for the Mac platform.
  • As for the Macs themselves, the new chipsets are coming to the flagship 14” and 16” versions of the MacBook Pro .
  • The M3 Pro and Max-equipped Pros now also come in a very sleek Space Black colorway.
  • Learn More about the Next Gen M3 Chip Macbooks Pros, iMacs at B&H Explora

ToughBuilt Industries Launched Innovative StackTech™ Line: A Mobile Stacking Tool Organization Ecosystem

Retrieved on: 
Tuesday, October 24, 2023
Pros, USD, TBLT, Social media, Video game, Toolbox

ToughBuilt entered the Stacking Tool Storage and Toolbox market for the first-time beginning October 19th, 2023, with an initial roll out of more than 25 SKUs.

Key Points: 
  • ToughBuilt entered the Stacking Tool Storage and Toolbox market for the first-time beginning October 19th, 2023, with an initial roll out of more than 25 SKUs.
  • StackTech™ is the world’s first auto-locking stacking tool storage solution with 14 unique features.
  • IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. ("ToughBuilt” or the Company”) (NASDAQ: TBLT; TBLTW), announced today that the Company has released its revolutionary StackTech™ mobile stacking toolbox system.
  • ToughBuilt's launch into the stacking Toolbox category has swept social media with an early preview of the product line, garnering more than 19 million impressions in just two weeks.

PicnicHealth Acquires AllStripes, Fortifying its Role as the Leader in Patient-Centered Healthcare Evidence Generation

Retrieved on: 
Monday, October 23, 2023
Technology, Biotechnology, Health, Apps, Applications, Other Health, Pharmaceutical, Oncology, Practice Management, Telemedicine, Virtual Medicine, Software, General Health, Internet, Data Management, Clinical Trials, Biomedical Research, Disease, Pros, Patient, Acquisition, Research, Nursing, Pharmaceutical industry

PicnicHealth, a patient-centered healthcare evidence generation company, today announced the acquisition of AllStripes, a platform dedicated to generating evidence about the rare disease community.

Key Points: 
  • PicnicHealth, a patient-centered healthcare evidence generation company, today announced the acquisition of AllStripes, a platform dedicated to generating evidence about the rare disease community.
  • This strategic consolidation establishes PicnicHealth as the leading patient-centric evidence generation partner within a rapidly evolving life sciences landscape.
  • PicnicHealth engages directly with patients to collect and curate comprehensive clinical data and patient-reported outcomes (PROs) to generate rich insights across patient healthcare journeys.
  • With AllStripes’ strong relationships across patient communities, PicnicHealth expands its footprint and enhances its ability to guide critical and deep evidence generation.

Somms.ai Brings AI Attribution for Artists and Original Works, Custom GenAI Models to the Enterprise Music Industry

Retrieved on: 
Wednesday, October 11, 2023
Authorship, Algorithm, MTV, AI, DNA, Society, American Society of Composers, Authors and Publishers, Music, PRO, LOS, Artificial intelligence, Napster, Creativity, Pros, ASCAP, Catalog, Composer, Native Instruments, Symphony, Beatport

The platform enables labels, distributors, artists, and rights holders to craft their own custom AI Music Models and attribute AI-generated music to their training data sources, enabling them to assert justifiable ownership, promote fair royalty payouts, and ethically forge new revenue streams.

Key Points: 
  • The platform enables labels, distributors, artists, and rights holders to craft their own custom AI Music Models and attribute AI-generated music to their training data sources, enabling them to assert justifiable ownership, promote fair royalty payouts, and ethically forge new revenue streams.
  • Founded by music industry insiders from Beatport, Napster, MTV, and Native Instruments, Somms.ai was developed with the core mission of helping artists and rights owners to take advantage of AI technology while also protecting their art.
  • “Training AI models on other people's material without consent is unethical and fundamentally detrimental to the industry,” said Sean Power, CEO of Somms.ai.
  • “We have invented the equivalent of PRO algorithms for measuring public performance for the enterprise music industry.

Almirall's Ilumetri® (tildrakizumab) Significantly Improves Wellbeing for Patients1 and Their Relatives2 in Moderate-to-Severe Plaque Psoriasis

Retrieved on: 
Wednesday, October 11, 2023
Biotechnology, Pharmaceutical, Health, Other Health, Pain, European Association for the Study of the Liver, TRIBUTE, Trial of the century, University Medical Center, Tildrakizumab, BME, Venereology, Safety, ALM, Congress, University Medical Center Schleswig Holstein, Itch, Quality of life (healthcare), Almirall, Pros, RCT, Grammatical mood, Skin, Patient, Quality of life, Medical device, Medical imaging, Psoriasis, Dermatology

Tildrakizumab significantly improved relatives’ wellbeing after 28 weeks.2

Key Points: 
  • Tildrakizumab significantly improved relatives’ wellbeing after 28 weeks.2
    During the congress held in Berlin from October 11th to 14th, Almirall presented 12 posters highlighting new data on tildrakizumab in patients with moderate-to-severe plaque psoriasis.
  • Additionally, the symposium titled “New Landmark on Psoriasis treatment: the POSITIVE study”, chaired by Prof. Dr. Matthias Augustin and Prof. Dr. Ulrich Mrowietz, will explore the impact of tildrakizumab on physical, social and mental wellbeing in psoriasis.
  • Understanding the broader implications of psoriasis is a significant advance in our field and underlines the importance of a holistic approach to its treatment.
  • These data demonstrate the consolidated effectiveness and safety of tildrakizumab in treating plaque psoriasis and patients’ overall wellbeing.

France to Be First Country to Launch Digimarc Recycle

Retrieved on: 
Thursday, October 5, 2023
Data Management, Technology, Environmental Issues, Environmental Health, Recycling, Other Technology, Green Technology, Software, Artificial Intelligence, Environment, Sustainability, Henkel, Organization, SKU, Corporation, EPR, DMRC, Pros, Extended producer responsibility, P&G, Plastic, Consumer

Digimarc Corporation (NASDAQ: DMRC), the pioneer in product digitization and leader in digital watermarking, announced today that France, selected by the HolyGrail initiative leadership team , will become the first country-wide implementation of Digimarc Recycle .

Key Points: 
  • Digimarc Corporation (NASDAQ: DMRC), the pioneer in product digitization and leader in digital watermarking, announced today that France, selected by the HolyGrail initiative leadership team , will become the first country-wide implementation of Digimarc Recycle .
  • Digimarc Recycle represents a revolution in the sortation, and thus recycling, of plastic waste.
  • ), Digimarc Recycle overcomes the limitations of today’s optical sorting technologies to drive a step change in the quality and quantity of recyclate.
  • “Digimarc is also engaged with other groups, across multiple continents, to open new Digimarc Recycle markets.

LUNA'S NEW AUDIO, VIDEO, AND MEDICAL IMAGE SOLUTIONS BRING PATIENT EXPERIENCE EVEN CLOSER TO RESEARCH AND DEVELOPMENT

Retrieved on: 
Wednesday, October 11, 2023
Partnership, Health, HIV disease progression rates, Community, Core, Human, Brain, GDPR, Trial of the century, HIPAA, MPH, Spine, Cancer, Business operations, Patient, FHIR, FDA, Data collection, Community-driven development, IRB, Syringomyelia, Pros, CCPR, SAN, Privacy, AND, Research, Chiari malformation, Mobile phone, Medical device, Pharmaceutical industry, Medical imaging, Chiari

Luna's community-to-discovery technology is IRB-approved, SOC2-certified, and compliant with HIPAA, GDPR, CCPR, and emerging worldwide data privacy regulations for international study participation.

Key Points: 
  • Luna's community-to-discovery technology is IRB-approved, SOC2-certified, and compliant with HIPAA, GDPR, CCPR, and emerging worldwide data privacy regulations for international study participation.
  • These features align with industry and regulatory requirements for PROs, genetic data, and a more comprehensive view of health and lived experience for therapeutic development.
  • "To truly understand the potential impact on severity, disease progression, and treatment options, researchers and clinicians need to study these medical images alongside PROs and other medical information.
  • To learn more about these features, start a community, and to access product materials, go to https://www.lunadna.com/researchers/#collect-health-data or contact [email protected] .